Table 1.
Baseline characteristics
| Characteristic | Intervention (N = 320) | Control (N = 305) |
|---|---|---|
| Age, years | 65 (56–71) | 65 (57–71) |
| Women | 158 (49%) | 158 (52%) |
| Men | 162 (51%) | 147 (48%) |
| Education level | ||
| Low | 111 (35%) | 117 (39%) |
| Medium | 105 (33%) | 85 (28%) |
| High | 103 (32%) | 100 (33%) |
| Missing | 1 (<1%) | 3 (1%) |
| Marital status, partner | 265 (83%) | 269 (88%) |
| Employment status, employed | 122 (38%) | 99 (33%) |
| Tumour type | ||
| Breast cancer | 66 (21%) | 72 (24%) |
| Colorectal cancer | 80 (25%) | 72 (24%) |
| Head and neck cancer | 99 (31%) | 86 (28%) |
| Lymphoma | 75 (23%) | 75 (25%) |
| Tumour stage | ||
| Stage I | 106 (35%) | 104 (36%) |
| Stage II | 73 (24%) | 70 (24%) |
| Stage III | 61 (20%) | 67 (23%) |
| Stage IV | 64 (21%) | 52 (18%) |
| Missing | 16 (5%) | 12 (4%) |
| Treatment | ||
| None or single treatment | 137 (43%) | 124 (41%) |
| Multimodal treatment | 183 (57%) | 181 (59%) |
| Comorbidities | ||
| None or one comorbidity | 249 (78%) | 229 (75%) |
| Multiple comorbidities | 71 (22%) | 76 (25%) |
| Time since diagnosis, months | 25.0 (16–41) | 29.0 (17–41) |
| 3–<12 months | 39 (12%) | 38 (13%) |
| 12–<24 months | 104 (33%) | 85 (28%) |
| 24–60 months | 177 (55%) | 182 (60%) |
| Treatment (n, %) | ||
| None or single treatment | 137 (43%) | 124 (41%) |
| Multimodal treatment | 183 (57%) | 181 (59%) |
| EORTC QLQ-C30 summary score | 85.3 (14.9) | 85.4 (13.6) |
Data are mean (SD), n (%), or median (IQR)